This higher efficacy might be explained by the E-antibiotics impacting both crucial short-lived proteins such as c-MYC and MCL-1 involved in stimulating cancer proliferation and survival, as well as mitoribosomes whose mt-r-proteins are translated by 80S ribosomes. The gene discussed is MCL1; the disease is cancer.